Nuvo Group Presents New Information Supporting Expanded Functionality of INVU™ Platform for Distant Excessive-Danger Being pregnant Monitoring at Society of Maternal Fetal Drugs’s forty second Annual Being pregnant Assembly | Information

, Nuvo Group Presents New Information Supporting Expanded Functionality of INVU™ Platform for Distant Excessive-Danger Being pregnant Monitoring at Society of Maternal Fetal Drugs’s forty second Annual Being pregnant Assembly | Information

[ad_1]

TEL AVIV, Israel, Feb. 3, 2022 /PRNewswire/ — Nuvo Group, a pacesetter in fashionable maternal-fetal well being, in the present day offered new medical information for INVUTM, the one FDA-cleared, prescription-initiated, distant being pregnant monitoring and administration platform, on the Society for Maternal Fetal Drugs (SMFM)’s 42nd Annual Being pregnant Assembly. The info, offered in a scientific poster, “Expertise with home-based, distant non-stress assessments, together with automated choice help for interpretation of reactivity,” demonstrates the feasibility of telehealth options for high-risk pregnancies via distant fetal non-stress assessments (NSTs) and the novel machine studying medical choice help system (CDSS) to detect fetal coronary heart price accelerations. This research comes on the heels of a latest publication within the American Journal of Obstetrics and Gynecology (AJOG) titled, “Novel uterine contraction monitoring to allow distant, self-administered nonstress testing,” which firmly establishes INVU’s distinctive capabilities as an revolutionary telehealth answer.

The research, carried out by researchers on the Perelman Faculty of Drugs on the College of Pennsylvania and Nuvo Group, and sponsored by Nuvo Group, was carried out with ladies who have been larger than 32 gestational weeks in a high-risk singleton being pregnant utilizing the INVU system at residence. The NSTs have been reviewed by clinicians by way of the INVU web-based supplier dashboard. Of the 30 at-home periods, clinicians deemed 27 such periods as interpretable, validating the power of the INVU system to remotely seize medical grade NSTs. Periods have been then analyzed by the CDSS for reactivity in comparison with the clinicians’ assessments. The CDSS accurately categorized 92.6 p.c of the interpretable NSTs in contrast with clinicians. As well as, the CDSS software decided the NST to be reactive a mean of 14 minutes earlier within the session, doubtlessly decreasing the size of NST periods and enhancing clinician workflow.

NSTs for high-risk pregnancies are frequent and historically carried out with a affected person and supplier in a medical setting. As soon as a being pregnant has been deemed excessive danger, which frequently occurs after 26-28 weeks of gestation, NSTs could also be beneficial a few times every week—and sometimes day by day. With INVU, pregnant sufferers are given the chance to conduct correct testing beneath the supervision of their physician from the consolation of residence. INVU safely and precisely shifts the purpose of care and frees up time for each the physician and the affected person.

“We’re more than happy with the research outcomes showcasing our capacity to efficiently conduct non-stress assessments remotely in addition to the following layer in our technological stack: the power to precisely help the medical workflow via an automatic medical choice help system,” says Amit Reches, chief know-how officer, Nuvo Group. “Taken collectively, these capabilities have the potential to considerably enhance being pregnant look after each the medical care group and expectant moms.”

“The outcomes of this analysis are very promising for the way forward for at-home being pregnant monitoring for high-risk pregnancies that sometimes require frequent physician visits,” stated Nadav Schwartz, MD, an affiliate professor of Obstetrics and Gynecology on the Perelman Faculty of Drugs on the College of Pennsylvania and a medical advisor to Nuvo Group. “At-home NST testing can increase choices and reduce the burden for pregnant ladies and their healthcare suppliers.”

About Nuvo Group

Based mostly in Tel Aviv, Israel, Nuvo Group Ltd. (“Nuvo”) is dedicated to reinventing being pregnant look after the twenty first century via new know-how, instruments, and practices for suppliers and expectant moms, together with the INVU by Nuvo™ platform, an FDA-cleared, prescription initiated distant being pregnant monitoring and administration system. The INVU™ sensor band allows the supply of distant non-stress assessments and maternal & fetal coronary heart price monitoring in the present day whereas pioneering new data-driven customized pathways that Nuvo believes will assist enhance well being outcomes for all ladies sooner or later. The know-how and patent property that underpin the INVU platform have been awarded a lot of trade recognitions, together with Quick Firm’s Subsequent Large Issues in Tech (2021), CB Insights’ Digital Well being 150 (2020), and MedTech Innovator’s Prime 50 MedTech Startups (2021), in addition to a number of grants from a few of the world’s main tutorial medical facilities and scientific our bodies. Nuvo is led by a various group of skilled enterprise and medical professionals, devoted information engineers, software program designers and proud dad and mom who embrace a collective mission to present each life a greater starting.

For extra data and full indications, contraindications, warnings and precautions together with directions to be used, go to: www.nuvocares.com.

, Nuvo Group Presents New Information Supporting Expanded Functionality of INVU™ Platform for Distant Excessive-Danger Being pregnant Monitoring at Society of Maternal Fetal Drugs’s forty second Annual Being pregnant Assembly | Information View authentic content material to obtain multimedia:https://www.prnewswire.com/news-releases/nuvo-group-presents-new-data-supporting-expanded-capability-of-invu-platform-for-remote-high-risk-pregnancy-monitoring-at-society-of-maternal-fetal-medicines-42nd-annual-pregnancy-meeting-301474406.html

SOURCE Nuvo Group

, Nuvo Group Presents New Information Supporting Expanded Functionality of INVU™ Platform for Distant Excessive-Danger Being pregnant Monitoring at Society of Maternal Fetal Drugs’s forty second Annual Being pregnant Assembly | Information



[ad_2]

Source link

Votar

Leave a Reply